Companies

Acquired by KnowBe4

Acquired by Apple

Acquired by Capital D

Acquired by Oracle

Acquired by Siemens

Acquired by ERT Inc

IPO: AREC

IPO: ORTX

IPO: FRLN

IPO: ACHL

IPO: MGTX

Acquired by Facebook

IPO: BKNG

Acquired by Anthropic

Explore our investments

Life Sciences investments
Investing since

2016

Albion Frontiers Strategy
Total investment

£2bn

Over $2bn of follow on funding for our companies
Public offerings

4 IPOs

On Nasdaq

Celebrating Innovation: The Harley Street HealthTech Pioneer Award

Read the article >

News

Harley Street Health District together with AlbionVC to accelerate access to breakthrough healthcare technologies

Read the article >

Transforming Focal Epilepsy Treatment: Our Investment in EpilepsyGTx

Read the article >

Companies

Achilles Therapeutics
https://achillestx.com/

Biopharmaceutical company developing precision T cell therapies

Sector: Life Sciences

Status: IPO
Apollo Therapeutics
https://apollotherapeutics.com/

biopharmaceutical company advancing a robust pipeline of potentially transformative therapeutic programs

Sector: Life Sciences

Status: Growth
Axovia Therapeutics
https://axoviatherapeutics.com/

Gene therapy company developing disease-transformative medicines for ciliopathies

Sector: Life Sciences

Status: Exited
Bloomsbury GTX
https://bloomsburygtx.com/

Biotechnology company developing potentially curative treatments for patients suffering from rare neurological and metabolic diseases

Sector: Life Sciences

Status: Exited
EpilepsyGTx
https://www.epilepsygtx.com/

Biotechnology company developing of cutting-edge gene therapies to treat focal refractory epilepsy

Sector: Life Sciences

Status: Early Stage
Epsilogen
https://epsilogen.com/

Immuno-oncology company targeting cancer with the IgE class of antibodies

Sector: Life Sciences

Status: Early Stage
Freeline
https://spurtherapeutics.com/

Biopharmaceutical company focused on the development of liver-directed gene therapies

Sector: Life Sciences

Status: IPO
Meira GTX
https://meiragtx.com/

Vertically integrated, clinical stage gene therapy company

Sector: Life Sciences

Status: IPO
NovalGen
https://www.novalgen.com/

Immuno-oncology company developing breakthrough bispecific therapies that can safely harness the immune system to fight cancer

Sector: Life Sciences

Status: Early Stage
Orchard Therapeutics
https://www.orchard-tx.com/

Biotechnology company bringing transformative gene therapies to patients with serious and life-threatening orphan diseases

Sector: Life Sciences

Status: IPO
Quell Therapeutics
https://quell-tx.com/

A clinical stage company transforming lives in immune mediated disease

Sector: Life Sciences

Status: Growth

Learn more
Senya Tx
https://www.senyatx.com/

Targeting LRG1 as a pathological regulator in a range of vascular diseases

Sector: Life Sciences

Status: Early Stage

Let’s connect